Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathy.
Saved in:
| Title: | Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathy. |
|---|---|
| Authors: | Ang SP; Department of Medicine, Rutgers Health/Community Medical Center, Toms River, NJ, USA. spa45@rutgers.edu., Chia JE; Department of Medicine, Texas Tech University Health Science Center, El Paso, TX, USA., Mukherjee D; Department of Medicine, Texas Tech University Health Science Center, El Paso, TX, USA.; Department of Cardiovascular Medicine, Texas Tech University Health Science Center, El Paso, TX, USA. |
| Source: | Heart failure reviews [Heart Fail Rev] 2025 Jul; Vol. 30 (4), pp. 759-770. Date of Electronic Publication: 2025 Mar 08. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9612481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7322 (Electronic) Linking ISSN: 13824147 NLM ISO Abbreviation: Heart Fail Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7322 |
|---|---|
| DOI: | 10.1007/s10741-025-10502-5 |
